期刊文献+

质子泵抑制剂预防应激性溃疡的合理性分析 被引量:5

Reasonability Analysis of Proton Pump Inhibitors for Stress Ulcer
下载PDF
导出
摘要 目的调查某院临床使用质子泵抑制剂(PPIs)预防应激性溃疡(SU)的情况,评价该类药物的用药合理性。方法抽查某院2015年1月有使用PPIs的住院患者病历403份。从预防SU的角度,对PPIs的用药指佂、用量、给药次数、溶媒、疗程、所选药物及联合用药的合理性进行评价。结果预防性使用PPIs的共222份,占总病历数的55.09%,其中不合理有77份,占预防用药病例的34.68%,主要表现在无指佂预防用药。结论某院PPIs预防SU的使用存在不合理现象,相关部门应加快制定PPIs的使用标准或规范,以提高PPIs的使用合理性。 Objective To investgate the prophylactic use of proton pump inhibitors for stress ulcer in a hospital and evaluate its rationality.Methods 403 medical records of inpatients which used PPIs in January 2015 were chose. What used for preventing stress ulcer were sampled for the evaluation of indications in prophylactic medication, dosage, delivery times, solvents, course of treatment, the selected drugs and drugs combination.Results There were 222 copies(55.09%) which used PPIs for prevening stress ulcer,77 copies of them(34.68%)were unreasonable. No indications was the main problems.Conclusion There are still some unreasonable situations on the prophylactic use of PPIs in a hospital,relevant department should speed up the development of proton pump inhibitors using standard or specification,in order to improve the rationality of PPIs in hospital.
出处 《中国卫生标准管理》 2016年第13期103-105,共3页 China Health Standard Management
关键词 质子泵抑制剂 应激性溃疡 合理用药 Proton pump inhibitors Stress ulcer Rational drug use
  • 相关文献

参考文献7

二级参考文献53

  • 1李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 2张法灿.胃食管反流病的全球定义和分类-胃食管反流病的蒙特利尔共识意见介绍[J].内科,2007,2(2):149-151. 被引量:21
  • 3卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5Argownik LE,Lix LM,Merge CJ,et al.Use of proton pumpinhibitors and risk of osteoporosis-related fractures[J].CMAJ,2008,179:319-326.
  • 6Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thieno- pyridines : a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastroin- testinal risks of antiplatelet therapy and NSAID use [ J ]. Am J Gastroenterol,2010,105 (12) :2533-2549.
  • 7Budha NR, Frymoyer A, Smelick GS, et al. Drug absorption interactions between oral targeted anticancer agents and PPIs:is pH-dependent solubility the Achilles heel of targeted therapy? [ J ]. Clin Pharmacol Ther, 2012,92(2) :203-213.
  • 8Walravens J,Brouwers J, Sprier I,et al. Effect of pH and comedication on gastrointestinal absorption of posaco- nazole: monitoring of intraluminal and plasma drug concentrations [ J ~. Clin Pharmacokinet, 2011,50 ( 11 ) : 725-734.
  • 9Budha NR, Frymoyer A, Smelick GS, et al. Drug absorption interactions between oral targeted anticancer agents and PPIs:is pH-dependent solubility the Achilles heel of targeted therapy? [ J 1. Clin Pharmacol Ther, 2012,92(2) :203-213.
  • 10Johnson MD, Hamilton CD, Drew RH,et al. A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution [ J ]. J Antimicrob Chemother ,2003,51 ( 2 ) :453-457.

共引文献923

同被引文献40

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部